Episode 1 Part A: Signs and Symptoms of CKD and T2D
Episode 1 Part A: Signs and Symptoms of CKD and T2D
Establishing a Best Practice Between Primary Care and Specialists
Establishing a Best Practice Between Primary Care and Specialists
Episode 1 Part B: Diagnosis, Monitoring, and Risk Assessment
Episode 1 Part B: Diagnosis, Monitoring, and Risk Assessment
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Call to Action: Utilizing Avacopan to Improve AAV Care
Call to Action: Utilizing Avacopan to Improve AAV Care
MACE and SGLT2 Inhibitors: Do They Have an Impact?
MACE and SGLT2 Inhibitors: Do They Have an Impact?
Staging Coronary Risk: A New TRANSFORMative Approach
Staging Coronary Risk: A New TRANSFORMative Approach
TRANSFORM Trial: Overview and Potential Implications
TRANSFORM Trial: Overview and Potential Implications
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
